Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases.

In this study we reviewed the post-mortem cases in the years 1999-2004 that were presented at the Netherlands Forensic Institute. The concentrations of amphetamine-based drugs in femoral blood from cases of suspected unnatural death were compared with concentrations in whole blood from non-fatal cases of driving under the influence (DUI cases) and with literature. Furthermore, the combinations with other drugs and/or alcohol were investigated. Amphetamine-based drugs were present in 70 post-mortem cases and 467 DUI cases. The most detected amphetamine-based drug was MDMA, followed by amphetamine. The presence of MDA could usually be explained by metabolism of MDMA. Methamphetamine and MDEA were rarely present. Frequently, the amphetamine-based drugs were taken in combination with alcohol and/or other non-amphetamine-based drugs such as cocaine or cannabinoids. The 70 post-mortem cases were divided into 38 amphetamine-based drug caused (i.e. the amphetamine-based drug directly caused or contributed to the death) and 32 amphetamine-based drug related deaths (i.e. death was not directly caused by the amphetamine-based drug). In the latter category, other (poly)drug intoxications and death by violence or drowning were the most frequent causes of death. In 30 cases, MDMA caused death directly. The range in blood concentrations of MDMA in these cases was substantial, i.e. 0.41-84 mg/L with a median concentration of 3.7 mg/L (n=30). MDMA blood concentrations in the MDMA related deaths (n=20) and in the DUI cases (n=360) varied up to 3.7 and 4.0 mg/L, respectively. Seven victims died from the direct effects of amphetamine; the blood concentration of amphetamine ranged from 0.24 to 11.3 mg/L, with a median concentration of 1.7 mg/L (n=7). The median concentrations of amphetamine in the amphetamine related deaths (n=13) and the DUI cases (n=208) were much lower, i.e. 0.28 and 0.22 mg/L, respectively. Amphetamine blood concentrations up to 6.0 and 2.3 mg/L were seen in the drug related deaths and DUI cases, respectively. The most frequently encountered amphetamine-based drugs in the investigated deaths were MDMA and amphetamine. The majority of MDMA- and amphetamine-caused deaths, i.e. 90% of these deaths, occurred with blood concentrations above 1.5 and 0.80 mg/L, respectively. MDMA and amphetamine blood concentrations in drug related deaths and DUI cases, however, overlap the range of fatal concentrations. Therefore, MDMA or amphetamine concentrations should never be used alone to establish the cause of death.

[1]  W. Neuteboom,et al.  A new device for automation of the alcohol analysis performed by means of the adh-method , 1981 .

[2]  A. Jones,et al.  Abnormally high concentrations of amphetamine in blood of impaired drivers. , 2005, Journal of forensic sciences.

[3]  W. Lambert,et al.  Amphetamines as Potential Inducers of Fatalities: A review in the district of Ghent from 1976-2004 , 2006, Medicine, science, and the law.

[4]  P. Zweipfenning,et al.  Driving under the influence of alcohol and/or drugs in the Netherlands 1995-1998 in view of the German and Belgian legislation. , 2001, Forensic science international.

[5]  B. Ludes,et al.  GHB in postmortem toxicology. Discrimination between endogenous production from exposure using multiple specimens. , 2004, Forensic science international.

[6]  I. Bosman,et al.  Forensic cases involving the use of GHB in The Netherlands. , 2003, Forensic science international.

[7]  T. Tena,et al.  Amphetamine derivative related deaths. , 1997, Forensic science international.

[8]  N. Vassiliadis,et al.  Amphetamine derivative related deaths in northern Greece. , 2002, Forensic science international.

[9]  Randall C. Baselt,et al.  Disposition of toxic drugs and chemicals in man , 1982 .

[10]  H. Kalant,et al.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[11]  R. de la Torre,et al.  Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. , 2000, British journal of clinical pharmacology.

[12]  S. Elliott MDMA and MDA concentrations in antemortem and postmortem specimens in fatalities following hospital admission. , 2005, Journal of analytical toxicology.

[13]  Patrice Mangin,et al.  Concentration of drugs in blood of suspected impaired drivers. , 2005, Forensic science international.

[14]  S. Elliott Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of findings. , 2004, Journal of analytical toxicology.

[15]  W. Lambert,et al.  Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities. , 2004, Forensic science international.

[16]  M. Schulz,et al.  Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. , 2003, Die Pharmazie.

[17]  D. Wright,et al.  Shedding new light on the "safe" club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities. , 2004, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[18]  AC Moffat,et al.  Clarke's analysis of drugs and poisons , 2003 .

[19]  F. Musshoff,et al.  Fatal blood and tissue concentrations of more than 200 drugs. , 2004, Forensic science international.

[20]  X. H. Chen,et al.  Solid-phase extraction for the screening of acidic, neutral and basic drugs in plasma using a single-column procedure on Bond Elut Certify. , 1990, Journal of chromatography.

[21]  R. Baselt,et al.  In vitro stability of endogenous gamma-hydroxybutyrate in postmortem blood. , 1999, Journal of forensic sciences.

[22]  M. Repetto Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans. , 1997, Journal of toxicology. Clinical toxicology.

[23]  J. Gill,et al.  Ecstasy (MDMA) deaths in New York City: a case series and review of the literature. , 2002, Journal of forensic sciences.

[24]  G. Martinotti,et al.  Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002 , 2003, Human psychopharmacology.